A thriving community of collaborators
Meet our residents
When you join PHTA, you’ll become part of a vibrant community of complementary, pioneering businesses – and, uniquely, you’ll have the golden opportunity to collaborate with key opinion leaders and specialty experts from across Birmingham’s health and life sciences district.
Here’s a snapshot of the businesses and organisations who are already benefiting from PHTA’s state-of-the-art facilities and distinctive covening power…
As PHTA’s anchor resident, Clinical Immunology Services (CIS) provides a comprehensive range of accredited lab services to facilitate diagnoses of an array of conditions.
Its mission is to develop high-quality, reliable immunology diagnostics and services that set new standards in healthcare, driving global improvements in patient care and health economic outcomes.
As part of the national Health Innovation Network, funded by NHS England, HIWM catalyses collaboration between academia, industry, health and care providers, commissioners and citizens, supporting the development of healthcare innovations and giving patients access to the most effective medical discoveries, sooner.
Impli is a pioneering health technology company developing biosensors for real-time hormone monitoring.
Focusing initially on improving women’s health, Impli’s subdermal implant is designed to help clinicians and patients understand hormonal fluctuations to make better-informed treatment decisions for menopause, polycystic ovary syndrome (PCOS), and across fertility pathways including IVF.
Samoco designs smart medical transport device solutions to address delivery and last-mile issues in extreme environments, with both military and civilian applications.
Its mission is to revolutionise life-saving medical transport by designing efficient, drone and vehicle-integrated platforms that rapidly deliver medical resources, reducing time and saving lives.
KIFFIK’s platform delivers continuous molecular data from interstitial fluid for faster clinical trials, precision medicine, and companion diagnostics.
Interstitial fluid (ISF) bathes every cell in the body. It carries critical information: including biomarkers tied to inflammation, immune function, and metabolic activity. KIFFIK’s patented, point-of-care technology is the first to extract ISF non-invasively and painlessly.
Inteliphage’s mission is to make personalised phage therapy accessible and reliable in clinical practice, enabling healthcare professionals to address difficult-to-treat bacterial infections when standard treatment options fail. To achieve this, Inteliphage is developing an integrated platform that brings together phage susceptibility testing, a phage library focused on clinically relevant bacterial strains, the capabilities required for quality-assured phage supply, and support for clinical implementation.
HORIBA develops and delivers innovative analytical, diagnostic and automation solutions that support the life sciences industry, from drug development and biopharmaceutical manufacturing to clinical diagnostics that transform the healthcare journey. Working closely with its customers, HORIBA provides technologies for microbial testing, protein analysis and characterisation, process analytical technology (PAT), product integrity and quality assurance and in vitro diagnostics (IVD) solutions.
Osler is a UK-based diagnostics company whose purpose is to enable anyone, anywhere, to access, understand, and act on their health. It has has developed the Osler Origin® – a ‘portable lab’ that can provide lab-quality diagnostics to anyone, anywhere, at any time. The company was formed out of the University of Oxford in 2017, following decades of research from the same department that invented the portable electrochemical blood glucose sensor.
Founded in 2017, Atun Kimya develops and manufactures process chemicals for the hot-dip galvanising industry, combining chemical manufacturing with consultancy, technical monitoring and specialist metal and chemical analysis services.
Plug and Play is dedicated to driving innovation within large organisations, helping them stay ahead of the curve and thrive in today’s rapidly evolving business landscape. By selecting strategically-aligned start-ups that meet their unique tech challenges, Plug and Play’s partners benefit from first-hand insights into technological trends and networking opportunities with industry leaders.
Powered by machine learning models trained on diverse datasets to ensure accuracy across all skin tones, Naevi is a mole-tracking app designed for the early detection of skin cancer, helping patients and clinicians track and monitor even the most subtle, slow-moving changes in lesions over time.
NEWAVX is advancing a new era in human biology and injury recovery through its non-drug mechanical stimulus designed to deliver key biological effects typically associated with exercise, without requiring physical exertion. Rather than replacing exercise, the technology is intended to bridge the gap between exercise and medicine in settings where conventional movement-based rehabilitation and medical infrastructure are limited or unavailable.